DelveInsight's Frontotemporal Dementia Market Insights report includes a comprehensive understanding of current treatment ...

The overall market for frontotemporal dementia is expected to grow with the anticipated launch of emerging therapies, including Latozinemab, PBFT02, TAK-594/DNL593, and others, increased awareness ...

Cipla share price: Cipla Ltd shares fell the most in terms of percentage among all the 50 companies in the NSE Nifty today on Wednesday, October 30, 2024. Cipla share price: Cipla Ltd shares fell ...

Cipla's management emphasizes philanthropy, social impact, and future investments in biotech, gene therapy, and advanced treatment methods.

Cipla gets approval to introduce antibiotic injection to treat UTIs in India Cipla USA, a subsidiary of Cipla, holds the patent for plazomicin sulfate, an intravenous aminoglycoside administered ...

Cipla announced that it filed two generic respiratory drug applications with the US FDA in the last quarter, including a generic version of Symbicort and one other undisclosed inhalation product.

New Delhi: Pharmaceutical major Cipla Ltd has invested ₹ 42 crore in GoApptiv, increasing its stake in the digital tech company to 22.99% on a diluted basis.

Cipla rebounds after drug maker seeks to allay investors’ concerns on its Pithampur facility Cipla USFDA news: Cipla said there was no new development requiring additional disclosure on the matter.

Cipla, a pharmaceutical company, announced on Tuesday that it has started using drones to transport crucial medicines to hospitals and pharmacies in Himachal Pradesh in collaboration with Skye Air ...

Cipla, a pharmaceutical company based in Mumbai, has partnered with Skye Air Mobility to introduce drone-powered deliveries of critical medicines to hospitals and pharmacies in Himachal Pradesh ...

Cipla partners with Sky Air Mobility to deliver critical medicines to remote areas in Himachal Pradesh via drones. The initiative is the first of its kind for large Indian pharma companies and has ...